Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Mycobacterium genavense Infections in a Tertiary Hospital and Reviewed Cases in Non-HIV Patients.

Santos M, Gil-Brusola A, Escandell A, Blanes M, Gobernado M.

Patholog Res Int. 2014;2014:371370. doi: 10.1155/2014/371370. Epub 2014 Feb 19.

2.

Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.

Sahuquillo-Arce JM, Selva M, Perpiñán H, Gobernado M, Armero C, López-Quílez A, González F, Vanaclocha H.

Antimicrob Agents Chemother. 2011 Mar;55(3):1222-8. doi: 10.1128/AAC.00765-10. Epub 2011 Jan 10.

3.

[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].

Gimeno C, Cantón R, García A, Gobernado M; Grupo Español de Estudio de Doripenem.

Rev Esp Quimioter. 2010 Sep;23(3):144-52. Spanish.

4.

Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses.

Davia JL, Bel PH, Ninet VZ, Bracho MA, González-Candelas F, Salazar A, Gobernado M, Bosch IF.

Pediatr Dermatol. 2011 Jan-Feb;28(1):1-5. doi: 10.1111/j.1525-1470.2010.01161.x.

PMID:
20553401
5.

[Guidelines for the empirical antibiotic treatment of intra-abdominal infections].

Guirao X, Arias J, Badía JM, García-Rodríguez JA, Mensa J, Alvarez-Lerma F, Borges M, Barberán J, Maseda E, Salavert M, Llinares P, Gobernado M, García Rey C.

Rev Esp Anestesiol Reanim. 2010 Jan;57(1):41-60. Spanish. No abstract available.

PMID:
20196521
6.

[Antifungal prophylaxis in oncohematologic patients: Literature review and recommendations].

Cámara Rde L, Mensa J, Carreras E, Cuenca Estrella M, García Rodríguez JA, Gobernado M, Picazo J, Aguado JM, Sanz MA.

Med Clin (Barc). 2010 Feb 20;134(5):222-33. doi: 10.1016/j.medcli.2009.10.036. Epub 2009 Dec 29. Review. Spanish. No abstract available.

PMID:
20042205
7.

[Recommendations in the empiric anti-infective agents of intra-abdominal infection].

Guirao X, Arias J, Badía JM, García-Rodríguez JA, Mensa J, Alvarez-Lerma F, Borges M, Barberán J, Maseda E, Salavert M, Llinares P, Gobernado M, García Rey C.

Cir Esp. 2010 Feb;87(2):63-81. doi: 10.1016/j.ciresp.2009.09.014. Epub 2009 Nov 22. Spanish.

PMID:
19932472
8.

[Recommendations in the empiric anti-infective agents of intra-abdominal infection].

Guirao X, Arias J, Badía JM, García-Rodríguez JA, Mensa J, Alvarez-Lerma F, Borges M, Barberán J, Maseda E, Salavert M, Llinares P, Gobernado M, García Rey C.

Rev Esp Quimioter. 2009 Sep;22(3):151-72. Spanish.

9.

In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies.

Cantón E, Pemán J, Valentín A, Espinel-Ingroff A, Gobernado M.

Antimicrob Agents Chemother. 2009 Jul;53(7):3108-11. doi: 10.1128/AAC.00160-09. Epub 2009 Apr 20.

10.

[Treatment of fungal infections in patients with hematologic neoplasia].

Mensa J, De La Cámara R, Carreras E, Cuenca Estrella M, García Rodríguez JA, Gobernado M, Picazo J, Aguado JM, Sanz MA.

Med Clin (Barc). 2009 Apr 11;132(13):507-21. doi: 10.1016/j.medcli.2009.01.008. Epub 2009 Apr 5. Spanish. No abstract available.

PMID:
19345963
11.

[Automatic detection of bacterial and fungal infections in blood].

Molina JM, Córdoba J, Ramírez P, Gobernado M.

Enferm Infecc Microbiol Clin. 2008 Jul;26 Suppl 9:75-80. Review. Spanish.

PMID:
19195450
12.

Onychomadesis outbreak in Valencia, Spain, June 2008.

Salazar A, Febrer I, Guiral S, Gobernado M, Pujol C, Roig J.

Euro Surveill. 2008 Jul 3;13(27). pii: 18917. No abstract available.

13.

Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.

Cantón E, Pemán J, Valentín A, Bosch M, Espinel-Ingroff A, Gobernado M.

Diagn Microbiol Infect Dis. 2008 Oct;62(2):177-81. doi: 10.1016/j.diagmicrobio.2008.07.001. Epub 2008 Aug 8.

PMID:
18691842
14.

[The fungicidal activity and paradoxical effect of caspofungin against yeast. Influence of culture medium and incubation time].

Cantón E, Pemán J, Romero M, Valentín A, Gobernado M.

Rev Esp Quimioter. 2007 Dec;20(4):433-41. Spanish.

15.

[In vitro activity of ertapenem against clinical bacterial isolates in 69 Spanish medical centers (E-test study)].

Gobernado M, Sanz-Rodríguez C, Villanueva R, Torroba L, Redondo E, González-Esteban J.

Rev Esp Quimioter. 2007 Dec;20(4):395-408. Spanish.

16.

[Recommendations of antifungal treatment in patients with low grade immunosuppression].

Barberán J, Mensa J, Fariñas C, Llinares P, Serrano R, Menéndez R, Agustí C, Gobernado M, Azanza JR, García Rodríguez JA; Sociedad Española de Quimioterapia; Sociedad Española de Medicina Interna; Sociedad Española de Neumología y Cirugía Torácica.

Rev Esp Quimioter. 2008 Jun;21(2):127-42. Spanish.

17.

[Anidulafungin].

Gobernado M, Cantón E.

Rev Esp Quimioter. 2008 Jun;21(2):99-114. Review. Spanish.

18.

Voriconazole in the management of nosocomial invasive fungal infections.

Pemán J, Salavert M, Cantón E, Jarque I, Romá E, Zaragoza R, Viudes A, Gobernado M.

Ther Clin Risk Manag. 2006 Jun;2(2):129-58.

19.

Disseminated histoplasmosis with hemophagocytic syndrome in a patient with AIDS: description of one case and review of the Spanish literature.

Gil-Brusola A, Pemán J, Santos M, Salavert M, Lacruz J, Gobernado M.

Rev Iberoam Micol. 2007 Dec 31;24(4):312-6. Review.

20.

[Epidemiology of genotypic resistance of HIV-1 in Valencia. A 4-year study].

Molina JM, Córdoba J, Gil A, Gobernado M.

Rev Esp Quimioter. 2007 Sep;20(3):346-53. Spanish.

21.

[Ertapenem].

Gobernado M, Acuña C.

Rev Esp Quimioter. 2007 Sep;20(3):277-99. Review. Spanish. No abstract available.

22.

Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.

Gobernado M, Valdés L, Alós JI, Garcia-Rey C, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for E. coli Urinary Pathogens.

Rev Esp Quimioter. 2007 Jun;20(2):206-10.

23.

Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period.

Pemán J, Bosch M, Cantón E, Viudes A, Jarque I, Gómez-García M, García-Martínez JM, Gobernado M.

Diagn Microbiol Infect Dis. 2008 Jan;60(1):109-12. Epub 2007 Sep 21.

PMID:
17889486
24.

[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review].

Pemán J, Ortiz R, Osseyran F, Pérez-Bellés C, Crespo M, Chirivella M, Frasquet J, Quesada A, Cantón E, Gobernado M.

Rev Iberoam Micol. 2007 Jun;24(2):157-60. Review. Spanish.

25.

Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.

Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Urinary Pathogens.

Rev Esp Quimioter. 2007 Mar;20(1):68-76.

26.

[Daptomycin. Reassessment of an antibiotic].

Gobernado M.

Rev Esp Quimioter. 2007 Mar;20(1):11-8. Spanish. No abstract available.

27.

In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.

Sahuquillo Arce JM, Colombo Gainza E, Gil Brusola A, Ortiz Estévez R, Cantón E, Gobernado M.

Rev Esp Quimioter. 2006 Sep;19(3):252-7.

28.

[Bacterial resistance and a new antibiotic: tigecycline].

Gobernado M.

Rev Esp Quimioter. 2006 Sep;19(3):209-19. Review. Spanish. No abstract available.

29.

Value of semen culture in the diagnosis of chronic bacterial prostatitis: a simplified method.

Budía A, Luis Palmero J, Broseta E, Tejadillos S, Benedicto A, Queipo JA, Gobernado M, Fernando Jiménez Cruz J.

Scand J Urol Nephrol. 2006;40(4):326-31.

PMID:
16916775
30.

Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections.

de Llanos R, Querol A, Pemán J, Gobernado M, Fernández-Espinar MT.

Int J Food Microbiol. 2006 Aug 1;110(3):286-90. Epub 2006 Jun 19.

PMID:
16782223
31.

[Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes].

Baquero F, Cercenado E, Cisterna R, de la Rosa M, García-Rodríguez JA, Gobernado M, Pérez JL, Manchado P, Martín R, Pascual A, Picazo J, Prats G, Rubio C, Snyder TA, Sanz-Rodríguez C.

Rev Esp Quimioter. 2006 Mar;19(1):51-9. Spanish.

32.

[In vitro activity of voriconazole against yeast and algae isolates according to new resistance pattern cut-off points].

Pemán J, Cantón E, Calabuig E, Bosch M, Valentí A, Viudes A, Gobernado M.

Rev Esp Quimioter. 2006 Mar;19(1):21-33. Review. Spanish.

33.

[Activity of voriconazole against yeasts isolated from blood culture determined by two methods].

Cantón E, Pemán J, Bosch M, Viudes A, Gobernado M.

Rev Esp Quimioter. 2005 Dec;18(4):308-12. Spanish.

34.

[Antifungal inhibitors of glucan synthesis].

Romero M, Cantón E, Pemán J, Gobernado M.

Rev Esp Quimioter. 2005 Dec;18(4):281-99. Review. Spanish. No abstract available.

35.

[Extended-spectrum beta-lactamases on the rise].

Gobernado M.

Rev Esp Quimioter. 2005 Jun;18(2):115-7. Spanish. No abstract available.

36.

[In vitro susceptibility to antibiotics and the most common Streptococcus pneumoniae serotypes: a multicenter study].

Cantón E, Diosdado N, Montaner M, Gobernado M; Grupo del Estudio Multicéntrico.

Rev Esp Quimioter. 2005 Mar;18(1):45-51. Spanish.

37.

Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study.

Cantón E, Pemán J, Gobernado M, Alvarez E, Baquero F, Cisterna R, Gil J, Martín-Mazuelos E, Rubio C, Sánchez-Sousa A, Serrano C.

Antimicrob Agents Chemother. 2005 Apr;49(4):1604-7.

38.

Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.

Cantón E, Pemán J, Gobernado M, Viudes A, Espinel-Ingroff A.

Antimicrob Agents Chemother. 2005 Apr;49(4):1593-6.

39.

[Etiology and antimicrobial susceptibility among uropathogens causing community-acquired lower urinary tract infections: a nationwide surveillance study].

Andreu A, Alós JI, Gobernado M, Marco F, de la Rosa M, García-Rodríguez JA; Grupo Cooperativo Español para el Estudio de la Sensibilidad Antimicrobiana de los Patógenos Urinarios.

Enferm Infecc Microbiol Clin. 2005 Jan;23(1):4-9. Spanish.

PMID:
15701325
40.

[Hospital Universitario La Fe Guide to the prophylaxis and treatment of fungal infections in immunodepressed patients or in patients requiring special care].

Jarque I, Salavert M, Romá E, Gobernado M, Chiveli MA, Ruano M, Solé A, Poveda JL, Ferrer E, García-Pellicer J, Sanz MA, Pemán J, Sánchez V; Comision de Farmacia y Terapéutica.

Rev Esp Quimioter. 2004 Dec;17(4):357-89. Spanish. No abstract available.

41.

[Study of in vitro activity of caspofungin on non-Candida albicans yeast strains determined by two methods: M27-A2 and EUCAST].

Romero M, Cantón E, Pemán J, Gobernado M.

Rev Esp Quimioter. 2004 Sep;17(3):257-62. Spanish.

42.

Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.

Pemán J, Cantón E, Gobernado M; Spanish ECMM Working Group on Candidaemia.

Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):23-30.

PMID:
15619060
43.

[Rapid identification of Candida glabrata using a new commercial kit].

Pemán J, Aparisi N, García-Esteban C, Gobernado M.

Rev Iberoam Micol. 2004 Jun;21(2):82-4. Spanish.

44.

[Coverage of the 23-valent pneumococcal vaccine in those older than 64 years of age in the region of Castellon and Valencia, Spain].

Montaner M, Cantón E, Diosdado N, Moreno R, Ramos P, Igual R, González-Granda D, García-Aguayo JM, Canós M, Gobernado M.

Rev Esp Quimioter. 2004 Jun;17(2):155-60. Spanish.

45.

[Rifaximin].

Gobernado M, Ponce J.

Rev Esp Quimioter. 2004 Jun;17(2):141-53. Review. Spanish. No abstract available.

46.

[Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients].

Jarque I, Andreu R, Salavert M, Gómez D, Pemán J, Gobernado M, Sanz MA.

Rev Iberoam Micol. 2003 Sep;20(3):116-8. Spanish.

47.

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.

Odds FC, Motyl M, Andrade R, Bille J, Cantón E, Cuenca-Estrella M, Davidson A, Durussel C, Ellis D, Foraker E, Fothergill AW, Ghannoum MA, Giacobbe RA, Gobernado M, Handke R, Laverdière M, Lee-Yang W, Merz WG, Ostrosky-Zeichner L, Pemán J, Perea S, Perfect JR, Pfaller MA, Proia L, Rex JH, Rinaldi MG, Rodriguez-Tudela JL, Schell WA, Shields C, Sutton DA, Verweij PE, Warnock DW.

J Clin Microbiol. 2004 Aug;42(8):3475-82.

48.

Patterns of amphotericin B killing kinetics against seven Candida species.

Cantón E, Pemán J, Gobernado M, Viudes A, Espinel-Ingroff A.

Antimicrob Agents Chemother. 2004 Jul;48(7):2477-82.

49.

[Usefulness of the E-test and its assay conditions in the study of the interaction of antifungal agents. A pilot study].

Cantón E, Pemán J, Romero M, Gobernado M.

Rev Esp Quimioter. 2004 Mar;17(1):48-56. Spanish.

50.

[Serotypes and antibiotic susceptibility of Streptococcus pneumoniae in children in the health district of Valencia and Castellón, Spain: a multicenter, prospective trial].

Cantón E, Montaner M, Pérez-Bellés C, Román J, Moreno R, Igual R, González-Granda D, Gobernado M.

Rev Esp Quimioter. 2003 Dec;16(4):412-20. Spanish.

Supplemental Content

Loading ...
Support Center